Description

Envarsus (tacrolimus) Tablets with Prolonged Release 1 mg. #60

Envarsus is a medication that contains the active ingredient tacrolimus. It is available in the form of tablets with prolonged release, each containing 1 mg. of tacrolimus. This medication is commonly prescribed to prevent organ rejection in transplant recipients, particularly kidney, liver, and heart transplant patients. Envarsus is known for its efficacy in maintaining the balance of the immune system to prevent the body from attacking the transplanted organ.

What is Tacrolimus?

Tacrolimus is a type of immunosuppressant medication that works by inhibiting the activity of certain immune cells that are responsible for attacking foreign substances in the body, including transplanted organs. By suppressing the immune response, tacrolimus helps prevent rejection of the transplanted organ and allows the body to adapt to the new organ without complications.

Indications

Envarsus tablets with prolonged release are indicated for the prevention of organ rejection in transplant recipients. It is commonly used in the following types of organ transplants:

• Kidney transplants
• Liver transplants
• Heart transplants

Envarsus may be used in combination with other immunosuppressant medications as part of a comprehensive transplant treatment regimen prescribed by a healthcare provider.

Dosage and Administration

The recommended dosage of Envarsus (tacrolimus) Tablets with prolonged release may vary depending on the type of organ transplant, the patient’s weight, medical history, and other factors. It is important to follow the dosage instructions provided by the healthcare provider or pharmacist carefully.

Envarsus tablets should be taken orally with or without food, usually once daily at the same time each day. The tablets should be swallowed whole with a glass of water and should not be crushed, chewed, or broken.

It is important to take Envarsus exactly as prescribed by the healthcare provider to ensure the medication is effective in preventing organ rejection while minimizing the risk of side effects.

Side Effects

Like all medications, Envarsus (tacrolimus) Tablets with prolonged release may cause side effects in some patients. Common side effects of tacrolimus may include:

• Headache
• Nausea
• Vomiting
• Diarrhea
• Tremors
• High blood pressure

If any of these side effects persist or worsen, it is important to contact a healthcare provider for further evaluation and guidance. In some cases, tacrolimus may cause more serious side effects, such as kidney problems, nerve damage, or infections. Patients should seek immediate medical attention if they experience symptoms of a serious allergic reaction, such as rash, itching, swelling, severe dizziness, or difficulty breathing.

Precautions

Before starting treatment with Envarsus (tacrolimus) Tablets with prolonged release, patients should inform their healthcare provider about any existing medical conditions, allergies, or medications they are taking. It is important to disclose any history of liver or kidney problems, high blood pressure, infections, or cancer.

Patients should avoid consuming grapefruit or grapefruit juice while taking Envarsus, as it may interact with tacrolimus and affect its effectiveness. It is also important to limit exposure to sunlight and UV rays, as tacrolimus may increase the risk of sunburn and skin cancer.

Envarsus should not be used in pregnant women or women who are breastfeeding unless the potential benefits outweigh the risks. Patients should use effective contraception during treatment with tacrolimus to prevent pregnancy.

Drug Interactions

Envarsus (tacrolimus) Tablets with prolonged release may interact with other medications, supplements, or herbal products. It is important to inform the healthcare provider about all the medications being taken to avoid potential drug interactions. Some medications that may interact with tacrolimus include:

• Antibiotics
• Antifungal medications
• Antiviral medications
• Calcium channel blockers
• Corticosteroids

Patients should not start or stop any medication without consulting a healthcare provider while taking Envarsus to prevent potential interactions that may affect the effectiveness of the medication.

Storage

Envarsus (tacrolimus) Tablets with prolonged release should be stored at room temperature away from moisture and heat. The medication should be kept in its original packaging and stored out of reach of children and pets. Patients should not use Envarsus tablets that are past the expiration date or that appear to be damaged or tampered with.

Conclusion

Envarsus (tacrolimus) Tablets with prolonged release 1 mg. are an important medication for preventing organ rejection in transplant recipients. By inhibiting the immune response, tacrolimus helps transplant patients maintain the function of their transplanted organs and improve their quality of life. It is essential for patients to follow the dosage instructions, precautions, and storage guidelines provided by the healthcare provider to ensure the safe and effective use of Envarsus.